| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alzheimer's disease and other dementias: update on research
|
Schneider, Lon
|
|
2017
|
16 |
1 |
p. 4-5
2 p.
|
artikel
|
| 2 |
Alzheimer's disease pathology in synucleinopathies
|
Attems, Johannes
|
|
2017
|
16 |
1 |
p. 22-23
2 p.
|
artikel
|
| 3 |
Astroglial scarring after blast exposure: unproven causality
|
Hoge, Charles W
|
|
2017
|
16 |
1 |
p. 26-
1 p.
|
artikel
|
| 4 |
Astroglial scarring after blast exposure: unproven causality – Authors' reply
|
Shively, Sharon B
|
|
2017
|
16 |
1 |
p. 27-
1 p.
|
artikel
|
| 5 |
Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study
|
Schrag, Anette
|
|
2017
|
16 |
1 |
p. 66-75
10 p.
|
artikel
|
| 6 |
Cognitive impairment in Parkinson's disease
|
Majbour, Nour
|
|
2017
|
16 |
1 |
p. 23-24
2 p.
|
artikel
|
| 7 |
Combination therapy for treatment of infantile spasms
|
Riikonen, Raili
|
|
2017
|
16 |
1 |
p. 19-20
2 p.
|
artikel
|
| 8 |
Corrections
|
|
|
2017
|
16 |
1 |
p. 24-
1 p.
|
artikel
|
| 9 |
Corrections
|
|
|
2017
|
16 |
1 |
p. 24-
1 p.
|
artikel
|
| 10 |
DNA repair in the trinucleotide repeat disorders
|
Jones, Lesley
|
|
2017
|
16 |
1 |
p. 88-96
9 p.
|
artikel
|
| 11 |
Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial
|
Baulac, Michel
|
|
2017
|
16 |
1 |
p. 43-54
12 p.
|
artikel
|
| 12 |
Epilepsy research in 2016: new treatment directions
|
Berkovic, Samuel F
|
|
2017
|
16 |
1 |
p. 7-9
3 p.
|
artikel
|
| 13 |
Lacosamide monotherapy for newly diagnosed epilepsy
|
Brigo, Francesco
|
|
2017
|
16 |
1 |
p. 20-22
3 p.
|
artikel
|
| 14 |
Modern diagnosis of Flaubert's death mask
|
Charlier, Philippe
|
|
2017
|
16 |
1 |
p. 31-
1 p.
|
artikel
|
| 15 |
Movement disorders in 2016: from genes to phenotypes
|
Calabresi, Paolo
|
|
2017
|
16 |
1 |
p. 9-10
2 p.
|
artikel
|
| 16 |
Multiple sclerosis: the upward trajectory continues
|
Thompson, Alan
|
|
2017
|
16 |
1 |
p. 10-12
3 p.
|
artikel
|
| 17 |
Neurological infections in 2016: Zika and the rest
|
van de Beek, Diederik
|
|
2017
|
16 |
1 |
p. 17-18
2 p.
|
artikel
|
| 18 |
Neuromuscular diseases: hope and hurdles in clinical trials
|
Verschuuren, Jan J G M
|
|
2017
|
16 |
1 |
p. 12-13
2 p.
|
artikel
|
| 19 |
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis
|
Irwin, David J
|
|
2017
|
16 |
1 |
p. 55-65
11 p.
|
artikel
|
| 20 |
No miracle, just our brain
|
Morgan, Jules
|
|
2017
|
16 |
1 |
p. 32-
1 p.
|
artikel
|
| 21 |
Paediatric neurology in 2016: a year in review
|
Banwell, Brenda
|
|
2017
|
16 |
1 |
p. 14-15
2 p.
|
artikel
|
| 22 |
Placebos in clinical trials: unravelling a complex phenomenon
|
Mestre, Tiago A
|
|
2017
|
16 |
1 |
p. 28-29
2 p.
|
artikel
|
| 23 |
Placebos in clinical trials: unravelling a complex phenomenon – Authors' reply
|
Benedetti, Fabrizio
|
|
2017
|
16 |
1 |
p. 29-
1 p.
|
artikel
|
| 24 |
Rare advances for rare diseases
|
The Lancet Neurology,
|
|
2017
|
16 |
1 |
p. 1-
1 p.
|
artikel
|
| 25 |
Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial
|
O'Callaghan, Finbar J K
|
|
2017
|
16 |
1 |
p. 33-42
10 p.
|
artikel
|
| 26 |
Salzburg criteria: can we extend validation to critical care?
|
Roshdy, Ashraf
|
|
2017
|
16 |
1 |
p. 25-
1 p.
|
artikel
|
| 27 |
Salzburg criteria: can we extend validation to critical care? – Authors' reply
|
Leitinger, Markus
|
|
2017
|
16 |
1 |
p. 25-26
2 p.
|
artikel
|
| 28 |
Sex differences in the epidemiology, clinical features, and pathophysiology of migraine
|
Vetvik, Kjersti Grøtta
|
|
2017
|
16 |
1 |
p. 76-87
12 p.
|
artikel
|
| 29 |
Sleep in 2016: methodological issues and progress
|
Lammers, Gert Jan
|
|
2017
|
16 |
1 |
p. 15-17
3 p.
|
artikel
|
| 30 |
Stephen Kuffler
|
Akkermans, Rebecca
|
|
2017
|
16 |
1 |
p. 30-
1 p.
|
artikel
|
| 31 |
Stroke 1-2-0: a rapid response programme for stroke in China
|
Zhao, Jing
|
|
2017
|
16 |
1 |
p. 27-28
2 p.
|
artikel
|
| 32 |
Stroke research in 2016: when more medicine is better, and when it isn't
|
Rothwell, Peter M
|
|
2017
|
16 |
1 |
p. 2-3
2 p.
|
artikel
|
| 33 |
The most important advances in headache research in 2016
|
Jensen, Rigmor Hoejland
|
|
2017
|
16 |
1 |
p. 5-7
3 p.
|
artikel
|
| 34 |
Tsuneya Ikezu
|
|
|
2017
|
16 |
1 |
p. 31-
1 p.
|
artikel
|
Tijdschrift beschrijving